4
Changes in Ownership
C4 Therapeutics, Inc. Filed Acc 0001209191-21-047169
Director sold 755 shares at $37.37 ($28,214)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Salter Malcolm Director | 2021-07-16 | Sale | −755 | $37.37 | $28,214 | 14,427 | D |
| Open-market sales · 755 sh · avg $37.37 · $28,214 | |||||||
Loading xslF345X03/doc4.xml…